The company’s booked net premium earned of ₹5,136 crore in Q1 FY26, a 14% jump from ₹4,504 crore a year earlier. The insurer’s combined ratio inched up to 102.9%, versus 102.5% in the previous quarter and 102.3% in the year‑ago period.
Also Read: IRDAI starts action on 8 insurers over health portfolio lapses; ICICI Lombard, New India respond
It reported Gross Direct Premium Income (GDPI) of ₹7,735 crore in Q1 FY2026, reflecting a growth of 0.6% compared to ₹7,688 crore in Q1 FY2025. This was below the general insurance industry’s growth of 8.8% during the same period. However, excluding the impact of the 1/n accounting norm, the company’s GDPI grew by 4.8%, against the industry’s 12.8% growth.Profit before tax (PBT) for the quarter rose by 28.4% to ₹ 994 crore, compared to ₹774 crore in the corresponding period last year. Capital gains stood at ₹380 crore, up from ₹284 crore a year ago.
Return on Average Equity (ROAE) improved to 20.5% in Q1 FY2026 from 19.1% in Q1 FY2025. The solvency ratio remained stable at 2.70x as of June 30, 2025, slightly up from 2.69x as of March 31, 2025, and well above the minimum regulatory requirement of 1.50x. Advance premium stood at ₹ 3,807 crore as of June 30, 2025, up from ₹3,717 crore at the end of March 2025.
Also Read: June General Insurance Data: ICICI Lombard premiums drop 11%, New India Assurance outperforms
Investments made toward health distribution supported a 32.2% year-on-year growth in Retail Health for Q1 FY2026. The company’s Retail Health market share increased to 3.5% in Q1 FY2026 from 2.9% a year earlier. However, growth in the Group Benefit segment remained muted due to subdued credit disbursements and the impact of the 1/n accounting norms.
The results came after the close of the market hours. Shares of ICICI Lombard General Insurance Co Ltd ended at ₹2,003.20, down by ₹17.40 or 0.86% on the BSE.
